Gene: SLC23A3
Official Full Name: solute carrier family 23 member 3provided by HGNC
Gene Summary: Predicted to enable transmembrane transporter activity. Involved in hypoxanthine transport. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02591 | SLC23A3 Knockout cell line (HeLa) | Human | SLC23A3 | 1:3~1:6 | Negative | Online Inquiry |
KO02592 | SLC23A3 Knockout cell line (HCT 116) | Human | SLC23A3 | 1:2~1:4 | Negative | Online Inquiry |
KO02593 | SLC23A3 Knockout cell line (HEK293) | Human | SLC23A3 | 1:3~1:6 | Negative | Online Inquiry |
SLC23A3 Gene Knockout Cell Lines are genetically engineered cell lines that have had the SLC23A3 gene inactivated, allowing researchers to study the functional role of this gene in various biological processes. The SLC23A3 gene encodes a sodium-dependent transporter primarily involved in the uptake of essential nutrients, such as ascorbic acid (vitamin C) and its derivatives. By creating knockout versions of these cell lines, scientists can elucidate the gene's involvement in cellular metabolism, antioxidant defense, and overall cellular health.
The key function of these cell lines lies in their ability to provide a controlled environment where the effects of SLC23A3 deficiency can be observed. Mechanistically, the knockout eliminates the activity of the transporter, which can significantly impact cellular ascorbate levels, oxidative stress responses, and metabolic pathways associated with cell proliferation and survival. This allows for detailed exploration of how SLC23A3 influences cellular physiology under both normal and pathological conditions.
The scientific importance of SLC23A3 Gene Knockout Cell Lines extends to numerous research applications, including cancer biology, neurobiology, and immunology. These models can help in determining the role of ascorbate in tumor growth and progression, the neuroprotective effects in neuronal cells, and the immune response in various inflammatory diseases, thereby providing valuable insights that could translate into therapeutic interventions.
What sets SLC23A3 Gene Knockout Cell Lines apart from alternative cell lines is their specificity and reliability in gene function studies. Unlike transient expression systems or silencing techniques, knockout models offer a permanent modification, enabling long-term studies and reproducibility in experimental outcomes. This allows researchers to draw more accurate conclusions regarding the gene's function and its potential therapeutic targeting.
For researchers and clinicians, the availability of SLC23A3 Gene Knockout Cell Lines is invaluable. They present a unique opportunity to accelerate discoveries in gene function and disease mechanisms, ultimately paving the way for novel therapeutic strategies. Furthermore, our company is backed by a team of experts with extensive experience in genetic engineering and cellular biology, ensuring high-quality and reliable products that meet rigorous research standards.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.